Market Overview:
The global microbial chymosin market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for chymosin from the food & beverage, pharmaceutical, and biochemical engineering industries. Chymosin is a proteolytic enzyme that is used for cheese making and other applications such as meat tenderization, detergent formulation, and leather processing. The microbial chymosin market can be segmented on the basis of type into liquid, powder, and tablets. The liquid form of chymosin dominates the global microbial chymosin market owing to its easy handling and storage properties. On the basis of application, the food & beverage industry accounts for a major share of the global microbial chymosin market followed by pharmaceuticals and biochemical engineering industries. The growth in these industries is primarily driven by rising consumer demand for processed foods as well as innovative products with enhanced functionality such as longer shelf life or added health benefits.
Product Definition:
Microbial Chymosin is a protein enzyme that is produced by microorganisms, such as bacteria and fungi. It is used in the cheese-making process to help coagulate milk and form curds. Microbial chymosin can be more effective than traditional animal-derived chymosin in forming curds, and it also has a longer shelf life. This makes microbial chymosin an important tool for the cheese-making industry.
Chymosin Liquid:
Chymosin is a natural substance produced by the body and found in every cell. It acts as an enzyme to digest food and help break down proteins, fats, carbohydrates & vitamins. The main function of this enzyme is to release energy from foods so that cells can operate at the appropriate temperature for growth & division. Chymosin also helps build stronger bones, maintain ideal weight & prevent osteoporosis (thinning of bones).
Chymosin Powder:
Chymosin is a mold release agent that is extracted from the fungus,chymous. It has antifungal properties and helps prevent fungal growth in various products during industrial processing such as cheese making, meat processing, beer brewing and winemaking. Chymosin also finds application in pharmaceuticals for preventing fungal growth in biological samples during laboratory testing procedures such as blood transfusion or tissue biopsy.
Application Insights:
The food and beverage application segment led the global market in 2017. This was attributed to rising demand for processed meat products, such as bacon, ham and sausages among others. Furthermore, microbial chymosin is used in the production of cheese and yogurt owing to its ability to act as a culture medium for bacterial fermentation which improves the overall product quality.
Microbial chymosin acts as a suitable alternative to conventional animal-based chymosins due largely to its non-toxic nature and low cost of production. Moreover, it can be easily customized according with customer requirements through minor changes in manufacturing process leading to increased product adoption across various industries globally over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position through 2030, with the U.S., being the major contributor to regional growth. Rising demand for convenience foods and meat products is one of the key factors driving regional growth.
Growth Factors:
- Increasing demand for cheese and other dairy products: The global demand for cheese is projected to grow at a CAGR of 5.4% from 2016 to 2021. This will create opportunities for the microbial chymosin market as it is used in the production of cheese.
- Rising awareness about the health benefits of consuming cheese: Cheese is a rich source of nutrients such as protein, calcium, phosphorus, and vitamin B12, which makes it beneficial for overall health. This has led to an increase in its consumption worldwide, thereby driving the microbial chymosin market growth.
- Technological advancements in microbial chymosin production: The development of new technologies that improve the efficiency and yield of microbial chymosin production is expected to spur market growth over the forecast period. For instance, Inbiose (Belgium) has developed a process that uses genetically modified yeast strains for producing high-quality recombinant chymosins using sugarcane molasses as feedstock (a waste product from sugar refining). Such technological advancements are likely to boost adoption rates among producers and drive market growth over the forecast period..
Scope Of The Report
Report Attributes
Report Details
Report Title
Microbial Chymosin Market Research Report
By Type
Chymosin Liquid, Chymosin Powder, Chymosin Tablets
By Application
Food & Beverage, Pharmaceutical, Biochemical Engineering, Other
By Companies
Chr. Hansen Holding, Clarion Casein, Clover Fonterra Ingredients, DowDuPont, Osterreichische Laberzeugung Hundsbichler, Renco, Chr. Hansen Holding
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Microbial Chymosin Market Report Segments:
The global Microbial Chymosin market is segmented on the basis of:
Types
Chymosin Liquid, Chymosin Powder, Chymosin Tablets
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Food & Beverage, Pharmaceutical, Biochemical Engineering, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Chr. Hansen Holding
- Clarion Casein
- Clover Fonterra Ingredients
- DowDuPont
- Osterreichische Laberzeugung Hundsbichler
- Renco
- Chr. Hansen Holding
Highlights of The Microbial Chymosin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Chymosin Liquid
- Chymosin Powder
- Chymosin Tablets
- By Application:
- Food & Beverage
- Pharmaceutical
- Biochemical Engineering
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Microbial Chymosin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Microbial chymosin is a protein that helps to break down proteins. It is found in the stomach and small intestine of animals, and it can also be produced by some bacteria. Microbial chymosin is used to make cheese, yogurt, cottage cheese, and other dairy products.
Some of the key players operating in the microbial chymosin market are Chr. Hansen Holding, Clarion Casein, Clover Fonterra Ingredients, DowDuPont, Osterreichische Laberzeugung Hundsbichler, Renco, Chr. Hansen Holding.
The microbial chymosin market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Microbial Chymosin Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Microbial Chymosin Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Microbial Chymosin Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Microbial Chymosin Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Microbial Chymosin Market Size & Forecast, 2020-2028
4.5.1 Microbial Chymosin Market Size and Y-o-Y Growth
4.5.2 Microbial Chymosin Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Chymosin Liquid
5.2.2 Chymosin Powder
5.2.3 Chymosin Tablets
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Food & Beverage
6.2.2 Pharmaceutical
6.2.3 Biochemical Engineering
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Microbial Chymosin Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Microbial Chymosin Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Chymosin Liquid
9.6.2 Chymosin Powder
9.6.3 Chymosin Tablets
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Food & Beverage
9.10.2 Pharmaceutical
9.10.3 Biochemical Engineering
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Chymosin Liquid
10.6.2 Chymosin Powder
10.6.3 Chymosin Tablets
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Food & Beverage
10.10.2 Pharmaceutical
10.10.3 Biochemical Engineering
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Chymosin Liquid
11.6.2 Chymosin Powder
11.6.3 Chymosin Tablets
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Food & Beverage
11.10.2 Pharmaceutical
11.10.3 Biochemical Engineering
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Chymosin Liquid
12.6.2 Chymosin Powder
12.6.3 Chymosin Tablets
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Food & Beverage
12.10.2 Pharmaceutical
12.10.3 Biochemical Engineering
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Chymosin Liquid
13.6.2 Chymosin Powder
13.6.3 Chymosin Tablets
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Food & Beverage
13.10.2 Pharmaceutical
13.10.3 Biochemical Engineering
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Microbial Chymosin Market: Competitive Dashboard
14.2 Global Microbial Chymosin Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Chr. Hansen Holding
14.3.2 Clarion Casein
14.3.3 Clover Fonterra Ingredients
14.3.4 DowDuPont
14.3.5 Osterreichische Laberzeugung Hundsbichler
14.3.6 Renco
14.3.7 Chr. Hansen Holding
